Dexmedetomidine in gastrointestinal endoscopic procedures

Somchai Amornyotin
  • World Journal of Anesthesiology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)
  • DOI: 10.5313/wja.v5.i1.1

Dexmedetomidine in gastrointestinal endoscopic procedures

What is it about?

Gastrointestinal endoscopy is the gold standard in the examination and the treatment of the diseases of gastrointestinal system, but the disadvantage of being painful process. At this point the sedative and analgesic agents may be important. Dexmedetomidine is a new sedoanalgesic agent which is alternative to benzodiazepines and opioids.

Why is it important?

It has analgesia, amnesia, sedative and anxiolytic properties. The use of dexmedetomidine as the sole anesthetic agent and as the adjuvant analgesic agent has been published but has not been approved because of the inconsistency of efficacy and safety.

Perspectives

Somchai Amornyotin
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

This article is aimed to describe the use of dexmedetomidine in various gastrointestinal endoscopic procedures.

Read Publication

http://dx.doi.org/10.5313/wja.v5.i1.1

The following have contributed to this page: Somchai Amornyotin